Investing.com — Shares in British shopper items firm Reckitt Benckiser (LON:) hit their lowest stage in over 11 years on Monday after a U.S. jury discovered that Abbott Laboratories ‘ method brought on a woman to develop a harmful bowel illness, Reuters information reported.
The jury decided that Abbott (NYSE:) should pay $495 million in damages.
Practically 1,000 lawsuits have been filed in opposition to Abbott Laboratories, British peer Reckitt Benckiser , or each, in U.S. federal or state courts, the report added.
“That is prone to depress sentiment on the chance for each cited defendants,” Jefferies fairness analysts acknowledged in a notice cited by Reuters.
Reckitt Benckiser shares fell as a lot as 9.2% to 40.75 kilos per share, their lowest stage since January 2013. By 0724 GMT, shares had been down 8.1% at 41.20 kilos per share, heading for his or her greatest each day drop since March.
Abbott shares plunged 6.8% in pre-market US buying and selling.